IMVT — Immunovant Inc · $2.90B cap

Immunovant Inc (IMVT) is a biotechnology company listed on US.

Use this IMVT page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the IMVT quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the IMVT SEC filings page. Lician reads the product cache first so this HTML stays unique to Immunovant Inc even when a live quote feed is slow.

Immunovant Inc latest statements (FY2026)

Latest cached year on this hub. Full IMVT income, balance, and cash tables.

  • Revenue$0
  • Net Income-$505.6M
  • Total Assets$957.0M
  • Total Debt$0
  • Free Cash Flow-$407.3M

IMVT recent filings